In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companies: Tell More, Sooner

Executive Summary

If new disclosure rules proposed by the SEC become final as expected, they will make the Current Report Form 8-K filed by public companies more timely and more revealing--both about themselves and their partners. The rules stipulate 11 new reportable events, three of which are directly related to alliances, and the SEC also wants management to analyze the impact of the events they disclose. Life sciences lawyers say it's not fully clear what sorts of things companies in this sector will have to report: the impact of new 8-k rules will be decided with practice.
Advertisement

Related Content

Kimono Openings at Schering

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001952

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel